Emil W. Ciurczak has degrees in Analytical and Physical Chemistry from Rutgers and Seton Hall Universities. He has worked in pharmaceutical companies, performing analytical method development and method improvements, designing and modifying analytical devices. He is the winner of the EAS (2004) Award for Contributions to NIR. Read More
His column for Pharmaceutical Manufacturing, Therapeutic Dose, won the ASBPE 2007 Gold Award for “Regular Column, Contributed.” He was a pioneer for near-infrared for the pharmaceutical industry, introducing it at Sandoz in 1983 for raw material qualification. Some of the properties of pharma-ceutical materials (using NIR) reported by (published and presented) Emil include polymorphism, purity of optical isomers, mean particle size, dosage form assay, verification of clinical supplies verification, counterfeit detec-tion, and identification/qualification (he the was “beta site” for pioneer software from Technicon) of materials and dosage forms. He applied NIR to chromagraphic and dissolution testing, as well as for solid dosage form analyses.